Cost-Effectiveness of the Pneumococcal Conjugate Vaccine (10- or 13-Valent) Versus No Vaccination for a National Immunization Program in Tunisia or Algeria

Cost-Effectiveness of the Pneumococcal Conjugate Vaccine (10- or 13-Valent) Versus No Vaccination for a National Immunization Program in Tunisia or Algeria

Abstract Introduction To evaluate the expected impact of the Algeria national immunization program (NIP) and potential impact for a Tunisia NIP, this study assessed the public health and economic value of vaccination, through a cost-effectiveness analysis, for a PCV13 or PCV10 NIP, compared with no...

Full description

Bibliographic Details
Main Authors: Sarah J. Pugh, Mark A. Fletcher, Apostolos Charos, Lynda Imekraz, Matt Wasserman, Raymond Farkouh
Format: Article
Language:English
Published: Adis, Springer Healthcare 2018-12-01
Series:Infectious Diseases and Therapy
Subjects:
Algeria
Cost-effectiveness
PCV10
PCV13
Pneumococcal conjugate vaccine
Tunisia
Online Access:http://link.springer.com/article/10.1007/s40121-018-0226-x

Internet

http://link.springer.com/article/10.1007/s40121-018-0226-x

Similar Items